Ono Pharmaceutical

Company snapshot

Ono Pharmaceutical's headquarters in [Chūō-ku, Osaka](en.wikipedia.org/wiki/Ch%C5%AB%C5%8D-ku,), [Japan](en.wikipedia.org/wiki/Japan) Ono Pharmaceutical Co., Ltd. (小野薬品工業株式会社, Ono Yakuhin Kōgyō Kabushiki-gaisha) is one of the largest pharmaceutical companies in Japan. It is headquartered in [Chuo-ku, Osaka](en.wikipedia.org/wiki/Chuo-ku,_Osaka), Japan, with its major plants in [Higashinari-ku, Osa

• 4 active pipeline program(s) linked via ClinicalTrials.gov.
• 4 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for Ono Pharmaceutical. Not investment advice.

• What is Ono Pharmaceutical?

  Ono Pharmaceutical Co is a pharma organization headquartered in CN. Primary therapeutic focus areas include Gastric Cancer, Colorectal Cancer, Metastatic Pancreatic Cancer, Chronic Sinusitis. NovaPharmaNews links 4 clinical program(s), 0 drug profile(s), and 0 patent record(s) to

• Is Ono Pharmaceutical publicly traded?

  Ono Pharmaceutical appears in our database through regulatory marketing authorisation or clinical trial sponsor records; a US listed ticker is not shown for this entity.

• What drugs does Ono Pharmaceutical develop or market?

  We link 2 drug profile(s) where Ono Pharmaceutical is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/ono-pharmaceutical-co#company-drugs.

• What are the latest developments for Ono Pharmaceutical?

  In the last 12 months our linked public records show 4 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does Ono Pharmaceutical focus on?

  Ono Pharmaceutical focuses on Gastric Cancer, Colorectal Cancer, Metastatic Pancreatic Cancer based on our analysis of their pipeline programs and drug development activities.